Cynthia Dukes | Vice President, Drug Development, Rare Disease
ICON plc

Cynthia Dukes, Vice President, Drug Development, Rare Disease, ICON plc

Cynthia Dukes brings over 35 years of diversified clinical experience encompassing 29 years of clinical research experience in vaccines, oncology and infectious disease.  Cynthia began her clinical research experience as the Clinical Team Lead at Baylor College of Medicine’s Vaccine Treatment and Evaluation Unit and designated Influenza and Respiratory Disease Research Center where she gained valuable experience in vaccine and antiviral development. 
During her 10-year tenure at Pasteur Merieux Connaught (now Sanofi Pasteur), she was the clinical lead or product manager for multiple vaccines and oncology programs.  Subsequent to Pasteur Merieux Connaught she was the Sr. Director of Operations at ILEX Oncology providing oversight of up to 100 oncology studies (targeted therapies and oncology vaccines). 
While at ICON, Cynthia has been a significant contributor to the therapeutic areas of oncology, vaccines and infectious disease.   Whilst in pharma, Cynthia participated in more than 40 INDs leading to eight product approvals, including five vaccines, 2 oncology products and one immunoglobulin.   While at ICON she has provided strategic and management oversight on numerous pivotal studies leading to the approval of 9 vaccines and 5 oncology therapies.


April 15 Plenary Congress Day 1 @ 11:45

Seasonal vaccine studies: Critical success factors

Cynthia Dukes, VP, Scientific and Clinical Services and Head of Vaccine Center of Excellence, ICON Clinical Research – title TBC

April 16 Day 2 - 10 Co-conferences @ 10:10

Seasonal influenza vaccine efficacy studies: Lessons learned from 3 global studies

last published: 26/Mar/19 17:35 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071